(2E)-1-(2,4-dimethylphenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

2-ETHYNYLPYRAZINE, 95.0%, 5g

6-BROMO-4,4-DIMETHYL-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE, 95.0%, 250mg

4-(Imidazol-1-yl)benzylamine, 95.0%, 10g

Methyl 4-methoxy-1H-indole-6-carboxylate, 95.0%, 1g

4-(4-Chloro-6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazin-2-yl)morpholine, 95.0%, 1g

DIISOPROPYL 3-HYDROXYCYCLOBUTANE-1,1-DICARBOXYLATE, 95.0%, 100g

4-Bromo-2,3-difluorobenzenesulfonyl chloride, 95.0%, 250mg

HPLC-Vorsäulen NUCLEODUR®, 100-5 C8 ec, 4x3 mm, 3 Stück

Ethyl (2E)-3-(5-formyl-1-methyl-1H-pyrrol-2-yl)-2-propenoate, 250mg

AMONAFIDE, 97%, 1g

3-Amino-5-(hydroxymethyl)phenol, 95+%, 5g

2-Decyl-7-phenyl[1]benzothieno[3,2-b][1]benzothiophene [for organic electronics]>99.5%(HPLC)250mg